PT - JOURNAL ARTICLE AU - Obadia, Paul Musa AU - Mulaji, Gaylord Kalenda AU - Musambo, Taty Muta AU - Kitenge, Joseph Pyana AU - Kuhangana, Trésor Carsi AU - Kayembe-Kitenge, Tony AU - Nkulu, Célestin Banza Lubaba AU - Nemery, Benoit AU - Enzlin, Paul TI - Natural aphrodisiacs consumption by male workers in the former Katanga province, DR Congo AID - 10.1101/2024.02.07.24302074 DP - 2024 Jan 01 TA - medRxiv PG - 2024.02.07.24302074 4099 - http://medrxiv.org/content/early/2024/02/08/2024.02.07.24302074.short 4100 - http://medrxiv.org/content/early/2024/02/08/2024.02.07.24302074.full AB - Background In a previous cross-sectional study to determine the prevalence and determinants of erectile dysfunction (ED) among artisanal mineworkers, we found a significant association between ED and consumption of locally produced plant-derived aphrodisiacs.Aim We aimed to investigate the type and mode of consumption of aphrodisiacs, their possible health effects, and reasons for use among male workers in the Katanga province.Methods We conducted a mixed method study, first doing a survey (March 2021) among a convenience sample of 127 artisanal miners and 122 collective taxi-drivers. Participants responded to the International Index of Erectile Function (IIEF) questionnaire and had measurements of serum urea, creatinine, hepatic enzymes, total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides and sexual hormones. In a second qualitative phase, 16 participants, i.e., eight miners and eight drivers were interviewed.Results Self-reported regular (at least once a week) consumption of aphrodisiacs was significantly more prevalent among taxi-drivers (75%) than among miners (47%). Mild-to-moderate and moderate ED were reported more frequently by aphrodisiacs consumers [20/152 (13%)] than non-consumers [6/97 (6%)]. Five types of plant-derived aphrodisiacs (Zingiber officinale, Mitragyna stipulosa, Ocimum sp, Piper nigrum, Securidaca longepedunculata) were consumed, via the oral or anal routes, sometimes together with alcohol. We found no evidence of nephrotoxicity, hepatotoxicity or disturbances in serum levels of sex hormones. Themes that emerged from interviews related to cultural perceptions about masculinity, with miners using aphrodisiacs to support failing erectile function, and taxi-drivers taking aphrodisiacs for preventing ED.Conclusion We found a high prevalence of plant-derived aphrodisiacs use among working men in Katanga. While no serious adverse effects were identified, more ethno-botanical studies with isolation and rigorous identification of active constituents are needed to provide the poor population with correct information and to protect them against possible unwanted toxic effects.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by ARES CUD/ Belgium. No other role, apart from financial support, was played by this organization.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the Committee for medical Ethics of the Université de Lubumbashi (UNILU). Approval number: UNILU/CEM /144 /2018.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data for this study will be made available upon reasonable request to the corresponding author.